IL-6 is released from tumor cells and immune cells and is involved in tumor initiation, progression, and metastasis via activation of multiple intracellular signaling pathways, including the Janus kinase (JAK)/signal transducer and activator of transcription (STAT), phosphoinositide-3 kinase/AKT, RAS/mitogen-activated protein kinase (MAPK), MEK/extracellular signal-regulated kinase 5 (ERK5), and p38/JNK pathways3–5. The gene discussed is IL6; the disease is neoplasm.